Podcast
Author(s):
We traveled to Dallas, Texas, for a State of the Science Summit™ on Non–Small Cell Lung Cancer, which featured insights from Baylor Scott and White Health System faculty.
We recently traveled to Dallas, Texas for a State of the Science Summit™ on Non—Small Cell Lung Cancer. At the meeting, faculty from Baylor Scott and White Health System highlighted headway made in the treatment landscapes of non–small cell lung cancer according to histology, stage, and treatment intervention, the likes of which now include immunotherapy, targeted therapy, and chemotherapy.
Zongertinib Elicits Durable Responses in Pretreated Advanced HER2-Mutant NSCLC
Lenvatinib Shows Efficacy in Advanced HCC Post-Progression on Atezolizumab/Bevacizumab
Sacituzumab Govitecan Does Not Significantly Improve OS in Pretreated Urothelial Carcinoma
Active Monitoring Is Noninferior to Guideline Concordant Care in Low-Risk DCIS
2 Commerce Drive
Cranbury, NJ 08512